Skip to main content
. 2020 May 22;99(21):e20300. doi: 10.1097/MD.0000000000020300

Figure 2.

Figure 2

Secondary outcomes in the Tui Na and the control groups (E2 = estradiol, LH = luteinizing hormone, PRL = prolactin, P = progesterone, VAS = visual analogous scale). , P < .01 when comparing the Tui Na group with the control group in the post-treatment period.